Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
0.6500
+0.0012 (0.18%)
At close: Aug 1, 2025, 4:00 PM
0.6511
+0.0011 (0.17%)
After-hours: Aug 1, 2025, 7:44 PM EDT
Xilio Therapeutics Market Cap
Xilio Therapeutics has a market cap or net worth of $33.66 million as of August 1, 2025. Its market cap has decreased by -7.02% in one year.
Market Cap
33.66M
Enterprise Value
-47.55M
1-Year Change
-7.02%
Ranking
Category
Stock Price
$0.65
Market Cap Chart
Since the IPO on October 22, 2021, Xilio Therapeutics's market cap has decreased from $426.71M to $33.66M, a decrease of -92.11%. That is a compound annual growth rate of -48.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 33.66M | -22.91% |
| Dec 31, 2024 | 43.66M | 188.36% |
| Dec 29, 2023 | 15.14M | -79.46% |
| Dec 30, 2022 | 73.73M | -83.14% |
| Dec 31, 2021 | 437.33M | 2.49% |
| Oct 22, 2021 | 426.71M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 685.15B |
| Johnson & Johnson | 402.72B |
| AbbVie | 347.05B |
| AstraZeneca | 232.21B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 221.66B |
| UnitedHealth Group | 214.72B |
| Novo Nordisk | 211.90B |